Preexposure prophylaxis use increased in recent years
Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 ...
Renal & Urology News2d
HIV Preexposure Prophylaxis Use Increased in Recent Years
(HealthDay News) — Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association. Laura M. Mann ...
Success of long-lasting HIV drug hinges on pricing
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
News Medical on MSN2d
Affordability and supply remain critical to the success of long-lasting HIV drug
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
emjreviews.com5d
Pre-Exposure Prophylaxis Uptake Across US: IDWeek 2024
New IDWeek 2024 study reveals disparities in PrEP uptake across key U.S. populations. While overall PrEP usage has increased, ...
SciDev6d
Indigenous people with HIV ‘invisible’ in Latin America
“It’s alarming that new HIV acquisitions in Latin America increased by between 2010 and 2023 despite the advent of powerful new prevention tools like PrEP [Pre-Exposure Prophylaxis, a medicine to ...
News Medical6d
Exclusion of indigenous voices hinders HIV progress in Latin America
Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without access to life-saving medicines and prevention tools. The Latin America ...
News Medical4d
Sweden exceeds UNAIDS HIV goals but faces new challenges
Sweden has reduced its HIV incidence and surpassed the UNAIDS ... such as pre-exposure prophylaxis (PrEP), which is currently limited in Sweden to certain groups, such as men who have sex with ...
Medscape6d
HIV/AIDS
Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...
Science Daily4d
HIV and AIDS News
July 23, 2024 — Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global ...
Wall Street Journal5d
Weekend Interview: Trump Tangles With the Journal’s Editors
Kamala Harris becomes the first presidential candidate in 40 years to skip the 'Al Smith Catholic Charity Dinner' in New York—with Donald Trump taking full advantage of her absence. Photo ...
Medscape5d
Dolutegravir: A New HIV Integrase Inhibitor for the Treatment of HIV Infection
No writing assistance was utilized in the production of this manuscript. Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting ...